Clinical Trials Logo

Clinical Trial Summary

Primary Objective:

o To assess the change in percent of sexual attempts in which subjects are able to maintain an erection of sufficient duration to have successful intercourse between the run-in period and treatment period:

- The change in percent of sexual attempts in which subjects are able to insert the penis into the partner's vagina.

- The change in score on the erectile function (EF) domain of the International Index of Erectile Function (IIEF) questionnaire.

Secondary Objective:

o To evaluate the safety and tolerability of avanafil in patients with erectile dysfunction (ED).


Clinical Trial Description

The total study duration per patient will be up to 12 weeks, consisting of an 8-week treatment period and a 4-week run-in period. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02503306
Study type Interventional
Source Sanofi
Contact
Status Completed
Phase Phase 3
Start date July 2015
Completion date March 2016